SIPHAT was created in 1989 within the framework of the restructuring of the (Central Pharmacy of Tunisia). Since then, driven by the idea of progress, it made the health issue – issue of the future – into the field where its accumulated successes keep it at leadership level.

In partnership with several foreign laboratories (Abbott, Bayer, Sanofi,…) and in permanent collaboration with other Tunisian pharmaceutical industries, SIPHAT is at the service of health. Its priority is to meet the needs of its customers and partners and to propose highly performing health care quality.

Capital :

Assets: 9,000,000 dinars

Quotation on the Stock Exchange: as of May 2001

Allotment of shares :

1,800,000 shares of a nominal value of 5 dinars each, allocated as follows :

• “Central Pharmacy of Tunisia”: 67,77%
• Private shareholders: 32,23%

Establishment

SIPHAT is set up in the southern suburbs of Tunis, at 20 minutes from the down town and at 30 minutes from the Tunis Carthage airport.

Adresse : Fondouk Choucha, 2013 Ben Arous, Tunisia.

Production

We produce drugs of various galenic formulations :